Paget's Disease of Bone: Imaging Diagnosis, Differential Diagnosis, and Modern Management – A Comprehensive Radiology Case Review
Clinical Hook
A 57-year-old man initially presented with chronic right knee pain. Over time, he noticed progressive warmth and enlargement of his right thigh without significant limitation of joint motion. Conventional radiographs demonstrated extensive cortical thickening, coarse trabecular remodeling, and diffuse enlargement involving the right hemipelvis and femur. Bone scintigraphy revealed markedly increased radionuclide uptake throughout the involved skeleton, suggesting highly active bone remodeling. Although the total serum alkaline phosphatase level remained within the normal range, bone-specific alkaline phosphatase was significantly elevated, emphasizing that biochemical activity may remain occult unless bone turnover markers are specifically evaluated. Following risedronate therapy, clinical symptoms improved, and follow-up bone scintigraphy showed decreased metabolic activity after 18 months.
This representative case illustrates why Paget's disease continues to challenge clinicians despite its classic imaging appearance and highlights the indispensable role of multimodality imaging in diagnosis, disease activity assessment, and long-term therapeutic monitoring.
Learning Objectives
After completing this review, readers should be able to:
- Understand the pathophysiology of Paget's disease of bone.
- Recognize the characteristic radiographic features of active Paget's disease.
- Differentiate Paget's disease from metastatic bone disease and other sclerotic skeletal disorders.
- Interpret the complementary role of bone scintigraphy in evaluating disease extent and activity.
- Understand current therapeutic strategies, including bisphosphonate treatment.
- Appreciate emerging opportunities for artificial intelligence in musculoskeletal imaging.
Anatomy Review
Figure 1. Normal Bone Remodeling Cycle
Clinical Note:
Healthy adult bone undergoes continuous remodeling throughout life. The equilibrium between osteoclastic resorption and osteoblastic formation maintains skeletal strength while repairing microscopic damage. Paget's disease disrupts this tightly regulated process, leading to accelerated yet structurally disorganized bone turnover.
Case Presentation
Patient:
57-year-old male
Chief Complaint
Persistent right knee pain with progressive enlargement and warmth of the right thigh.
Clinical History
The patient reported gradually worsening discomfort involving the right lower extremity. Physical examination demonstrated asymmetric enlargement of the right thigh while preserving a normal range of knee motion. No acute traumatic event was identified.
Clinical Question
Does this patient's progressive osseous enlargement represent metabolic bone disease, malignant infiltration, or another chronic skeletal remodeling disorder?
Imaging Findings
Figure 2. Anteroposterior Radiograph of Both Knees
Radiographic Findings
Radiographs demonstrated:
- Marked cortical thickening involving the right femur
- Expansion of the involved bone
- Prominent coarse trabecular pattern
- Extension of trabecular thickening toward the subchondral bone
- Asymmetric osseous enlargement
These findings strongly suggested a chronic high-turnover bone remodeling process rather than aggressive malignancy.
Figure 3. Pelvic Radiograph
Additional Findings
Pelvic radiography demonstrated:
- Thickened iliopubic line
- Thickened ilioischial line
- Enlargement of the right hemipelvis
- Bilateral hip joint space narrowing
- Small sclerotic bone island within the proximal left femur
The combination of cortical expansion and coarse trabecular thickening represents one of the most recognizable imaging patterns of Paget's disease.
Figure 4. Bone Scintigraphy
Bone scintigraphy demonstrated markedly increased radionuclide uptake throughout the affected pelvis and femur, indicating metabolically active disease.
Unlike radiographs, which primarily depict structural alterations, bone scintigraphy reflects osteoblastic activity and provides valuable information on disease extent and biological activity.
Laboratory Findings
| Laboratory Test | Result | Interpretation |
|---|---|---|
| Total ALP | Normal | May remain normal in localized disease |
| Bone-specific ALP | Elevated | Active bone turnover |
| Bone Scan | Increased uptake | Active Paget disease |
Final Diagnosis
Paget's Disease of Bone (Osteitis Deformans)
A chronic metabolic skeletal disorder characterized by accelerated osteoclastic bone resorption followed by excessive yet architecturally disorganized osteoblastic bone formation, resulting in enlarged, mechanically weakened bone susceptible to deformity and fracture.
Imaging Pearls
1. Cortical Thickening Is the Earliest Radiographic Clue
One of the hallmark imaging findings of Paget's disease is diffuse cortical thickening accompanied by expansion of the involved bone. Unlike metastatic disease, which often destroys normal bone architecture, Paget's disease preserves the overall osseous contour while progressively enlarging the affected skeleton. In this case, cortical thickening of the right femur and pelvis represented the dominant imaging feature.
2. Coarse Trabecular Remodeling Reflects Accelerated Bone Turnover
The prominent trabecular thickening extending toward the subchondral region represents excessive yet disorganized osteoblastic repair following rapid osteoclastic resorption. Radiologists should recognize this "coarse trabecular pattern" as one of the most characteristic imaging signatures of Paget's disease rather than interpreting it as diffuse osteosclerosis.
3. Bone Enlargement Helps Differentiate Paget Disease
True enlargement of the affected bone is uncommon in metastatic disease but is highly characteristic of Paget's disease.
Typical manifestations include:
- Increased femoral diameter
- Pelvic enlargement
- Skull expansion
- Bowing deformity of long bones
Recognition of osseous enlargement substantially narrows the differential diagnosis.
4. Bone Scintigraphy Demonstrates Disease Activity Better Than Radiographs
Radiographs illustrate structural abnormalities, whereas bone scintigraphy evaluates metabolic activity by detecting increased osteoblastic turnover.
Bone scintigraphy is particularly valuable for:
- Determining disease extent
- Identifying polyostotic involvement
- Monitoring treatment response
- Detecting clinically silent lesions
In this patient, radionuclide uptake decreased after treatment, paralleling symptomatic improvement.
5. Normal Total ALP Does Not Exclude Active Disease
Localized Paget's disease may present with normal total alkaline phosphatase despite active skeletal remodeling.
Bone-specific alkaline phosphatase provides greater sensitivity and should be considered whenever imaging findings strongly suggest Paget's disease despite apparently normal biochemical screening.
Pathophysiology
Figure 5. Pathophysiologic Cascade of Paget's Disease of Bone
Cellular Mechanisms
Paget's disease is characterized by a profound disturbance in normal skeletal remodeling.
The disease progresses through three overlapping biological phases:
Phase 1. Osteolytic Phase
Hyperactive osteoclasts produce excessive bone resorption, creating structurally weakened bone.
Phase 2. Mixed Phase
Both osteoclastic destruction and osteoblastic repair occur simultaneously.
This phase is responsible for the classic radiographic appearance of:
- cortical thickening
- coarse trabeculation
- bone expansion
Phase 3. Sclerotic Phase
Osteoblastic activity predominates, producing enlarged but mechanically inferior woven bone.
Although bone density appears increased radiographically, the abnormal architecture predisposes patients to:
- insufficiency fractures
- deformity
- secondary osteoarthritis
- neurological compression in selected locations
The source document describes Paget's disease as excessive osteoclastic bone destruction followed by abnormal osteoblastic bone formation, resulting in enlarged, weakened, and deformable bone.
Epidemiology
Table 1. Epidemiologic Characteristics of Paget's Disease
| Characteristic | Description |
|---|---|
| Typical age | Older adults (commonly >50 years) |
| Sex | More common in men |
| Disease progression | Slowly progressive over years |
| Frequently involved bones | Pelvis, spine, skull, long bones |
| Clinical presentation | Often asymptomatic initially |
| Major complications | Fracture, deformity, osteoarthritis |
The source emphasizes that the pelvis, spine, skull, and long bones are the most commonly affected sites and that the disease usually progresses slowly over many years.
Clinical Manifestations
Clinical manifestations vary according to disease location and activity.
The attached case document identifies the following major clinical features:
- Persistent bone pain
- Progressive bone enlargement
- Skeletal deformity
- Pathologic fracture susceptibility
- Neurological symptoms due to nerve compression (uncommon)
- Joint stiffness
- Secondary osteoarthritis adjacent to involved bone
Bone pain remains the most frequent presenting symptom and may precede radiographic diagnosis by several years.
Differential Diagnosis
Table 2. Differential Diagnosis of Paget's Disease of Bone
| Disease | Key Imaging Findings | Distinguishing Features |
|---|---|---|
| Paget's Disease | Cortical thickening, coarse trabeculae, bone enlargement | Enlarged bone with preserved architecture; increased uptake on bone scintigraphy |
| Osteoblastic Metastasis | Multifocal sclerotic lesions | Usually no bone expansion; often associated with known primary malignancy |
| Fibrous Dysplasia | Ground-glass matrix with cortical thinning | Typically presents at a younger age; lacks coarse trabecular remodeling |
| Chronic Osteomyelitis | Cortical sclerosis with periosteal reaction | Clinical evidence of infection and inflammatory laboratory findings |
| Melorheostosis | Flowing cortical hyperostosis ("dripping candle wax") | Segmental distribution rather than diffuse osseous enlargement |
| Renal Osteodystrophy | Generalized skeletal sclerosis | Associated with chronic kidney disease and systemic metabolic abnormalities |
Diagnostic Approach
The diagnosis of Paget's disease should integrate:
- Clinical presentation
- Characteristic radiographic findings
- Bone turnover markers
- Bone scintigraphy to assess disease activity
In the present case, the combination of cortical thickening, coarse trabeculation, enlargement of the pelvis and femur, elevated bone-specific alkaline phosphatase, and increased radionuclide uptake strongly favored Paget's disease over malignant or infectious etiologies.
Clinical Management
The primary goals of treatment are:
- Reduce bone pain
- Suppress excessive bone remodeling
- Prevent skeletal deformity
- Minimize fracture risk
- Improve long-term quality of life
The source case describes successful treatment with risedronate, a bisphosphonate that inhibits osteoclast-mediated bone resorption. Following 18 months of therapy, both symptoms and bone scintigraphy findings improved, demonstrating reduced metabolic activity.
1. Bisphosphonate Therapy
Bisphosphonates remain the cornerstone of medical management by reducing osteoclastic activity and slowing disease progression.
Expected benefits include:
- Reduction of bone pain
- Normalization of bone turnover
- Prevention of progressive deformity
- Decreased risk of future complications
The case specifically documents treatment with risedronate, followed by clinical and scintigraphic improvement.
2. Pain Control
Symptomatic pain management may include:
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Other analgesics as clinically appropriate
Pain control is supportive and should accompany disease-directed therapy rather than replace it.
3. Physical Therapy
Rehabilitation aims to:
- Preserve joint mobility
- Improve muscle strength
- Enhance balance
- Reduce fall risk
- Maintain functional independence
Exercise programs should be individualized according to skeletal involvement and fracture risk.
4. Surgical Intervention
Although many patients respond to medical therapy, surgery may be required for:
- Pathologic fractures
- Severe skeletal deformity
- Progressive neurological compression
- Advanced secondary osteoarthritis requiring reconstruction
The source notes that surgical treatment may be necessary when complications such as fracture, deformity, or nerve compression occur.
5. Long-Term Follow-up
Regular follow-up is essential to:
- Monitor disease progression
- Evaluate treatment response
- Detect complications early
- Adjust therapeutic strategies when necessary
The case demonstrates the value of follow-up bone scintigraphy, which showed decreased radionuclide uptake after treatment, correlating with symptomatic improvement.
Artificial Intelligence Perspective
Figure 6. Enterprise AI Workflow for Paget's Disease Imaging
Artificial Intelligence in Paget's Disease Imaging
Although Paget's disease remains a relatively uncommon metabolic bone disorder, advances in musculoskeletal artificial intelligence are opening new opportunities for automated diagnosis, quantitative assessment, and longitudinal disease monitoring.
Unlike conventional computer-aided detection systems that focus solely on identifying abnormalities, modern AI platforms increasingly function as clinical decision-support systems, integrating imaging findings with laboratory biomarkers and patient history to assist radiologists in diagnosis and follow-up.
1. Automated Detection of Characteristic Imaging Features
Deep learning algorithms trained on musculoskeletal radiographs can identify several hallmark features of Paget's disease, including:
- Cortical thickening
- Coarse trabecular architecture
- Bone enlargement
- Altered bone geometry
- Mixed lytic-sclerotic remodeling
Such systems may improve detection of subtle or incidentally discovered lesions during routine imaging interpretation.
2. Quantitative Disease Burden Assessment
Rather than relying solely on qualitative descriptions, AI-based image analysis can provide objective measurements of:
- Cortical thickness
- Trabecular density
- Bone volume
- Skeletal asymmetry
- Disease extent across multiple bones
These quantitative metrics have the potential to enhance reproducibility and support standardized longitudinal assessment.
3. Longitudinal Treatment Monitoring
The source case demonstrated reduced radionuclide uptake on bone scintigraphy following 18 months of risedronate therapy, corresponding with clinical improvement.
AI-assisted image registration and quantitative comparison tools may facilitate:
- Automated comparison between serial radiographs
- Bone scintigraphy uptake analysis
- Detection of progressive deformity
- Visualization of treatment response over time
Such approaches could improve consistency in follow-up evaluations.
4. Enterprise Clinical Decision Support
Future enterprise imaging platforms may integrate:
- Radiographic findings
- Bone scintigraphy
- Bone-specific alkaline phosphatase levels
- Clinical symptoms
- Prior imaging examinations
to generate structured differential diagnoses and recommend evidence-based management pathways.
Importantly, these systems are intended to support, not replace, radiologist interpretation.
5. Current Limitations of AI
Despite significant technological progress, several challenges remain:
- Limited availability of large, annotated datasets for rare metabolic bone diseases
- Imaging variability across institutions
- Difficulty distinguishing Paget's disease from atypical metastatic or dysplastic lesions
- Need for external validation before widespread clinical implementation
At present, AI should be viewed as an adjunct to expert clinical and radiologic assessment rather than an autonomous diagnostic tool.
Future of Precision Imaging
The future of Paget's disease management lies in the convergence of advanced imaging, computational analysis, and personalized medicine.
Radiogenomics
Although the source document notes that the precise cause of Paget's disease remains uncertain and likely involves both genetic and environmental factors, it does not discuss radiogenomics specifically.
Looking ahead, radiogenomic approaches may enable researchers to correlate imaging phenotypes with underlying molecular characteristics, potentially improving disease classification and risk prediction.
Digital Twin
Digital twin technology may allow construction of individualized computational skeletal models capable of:
- Simulating disease progression
- Predicting biomechanical stress
- Estimating fracture risk
- Evaluating therapeutic response under different treatment scenarios
These applications remain investigational but represent a promising direction for precision musculoskeletal medicine.
Federated Learning
Because Paget's disease is relatively uncommon, federated learning offers a potential solution for developing robust AI models while preserving patient privacy.
By allowing institutions to train shared algorithms without exchanging raw patient data, federated learning may improve model generalizability across diverse populations.
Synthetic Data
The rarity of Paget's disease limits the availability of large imaging datasets for AI development.
Synthetic imaging generated through advanced machine learning techniques could augment training datasets, improve algorithm robustness, and facilitate research into uncommon skeletal disorders, provided that rigorous validation safeguards are maintained.
Clinical Pearls
- Bone enlargement is one of the most distinguishing imaging features of Paget's disease.
- Cortical thickening combined with coarse trabecular remodeling strongly suggests accelerated bone turnover.
- Bone scintigraphy is more sensitive than radiography for assessing the extent and metabolic activity of disease.
- A normal total alkaline phosphatase level does not exclude active Paget's disease; bone-specific alkaline phosphatase may be elevated.
- The pelvis and long bones are among the most frequently affected skeletal sites.
- Progressive skeletal deformity increases the risk of fracture and secondary osteoarthritis.
- Bisphosphonates remain the primary medical treatment for active disease.
- Follow-up imaging is essential for monitoring therapeutic response and disease progression.
- AI may enhance quantitative assessment and longitudinal monitoring but currently complements rather than replaces expert interpretation.
- Multimodality evaluation—including radiography, bone scintigraphy, laboratory markers, and clinical findings—is fundamental to accurate diagnosis and optimal management.
Quiz
Question 1
Which imaging finding is considered the most characteristic radiographic feature of Paget's disease of bone?
A. Periosteal reaction with cortical destruction
B. Diffuse osteoporosis
C. Cortical thickening with coarse trabecular remodeling and bone enlargement
D. Multiple punched-out lytic lesions
Answer: C
Question 2
Which imaging modality is most useful for evaluating the metabolic activity and skeletal extent of Paget's disease?
A. Ultrasound
B. Plain radiography
C. Bone scintigraphy
D. Mammography
Answer: C
Question 3
Which laboratory finding may remain normal despite active localized Paget's disease?
A. Bone-specific alkaline phosphatase
B. Total alkaline phosphatase
C. Serum calcium
D. Urinary hydroxyproline
Answer: B
The source case demonstrates a normal total alkaline phosphatase level despite an elevated bone-specific alkaline phosphatase concentration.
Question 4
Which medication was administered in this case?
A. Methotrexate
B. Prednisolone
C. Risedronate
D. Denosumab
Answer: C
Question 5
After 18 months of therapy, follow-up bone scintigraphy demonstrated:
A. Progressive disease
B. No interval change
C. Decreased radionuclide uptake
D. Multifocal skeletal metastases
Answer: C
Frequently Asked Questions (FAQ)
1. What is Paget's disease of bone?
Paget's disease of bone is a chronic skeletal remodeling disorder characterized by excessive osteoclastic bone resorption followed by disorganized osteoblastic bone formation, resulting in enlarged but structurally weakened bone.
2. Which bones are most commonly affected?
According to the source material, Paget's disease most frequently involves:
- Pelvis
- Spine
- Skull
- Long bones of the lower extremities
3. What symptoms should raise suspicion for Paget's disease?
Common clinical manifestations include:
- Persistent bone pain
- Progressive enlargement of the affected bone
- Skeletal deformity
- Joint stiffness
- Secondary osteoarthritis
- Increased susceptibility to fracture
- Occasionally neurological symptoms due to nerve compression
4. Is a normal alkaline phosphatase level sufficient to exclude Paget's disease?
No. The present case demonstrates that total alkaline phosphatase may remain within the normal range despite active disease, whereas bone-specific alkaline phosphatase may be elevated. Therefore, biochemical evaluation should be interpreted alongside imaging findings.
5. Why is bone scintigraphy important?
Bone scintigraphy is valuable for:
- Determining the extent of skeletal involvement
- Assessing disease activity
- Identifying clinically occult lesions
- Monitoring treatment response over time
In this case, follow-up scintigraphy documented decreased radionuclide uptake after therapy.
6. What is the first-line treatment?
The source identifies bisphosphonate therapy (risedronate) as the treatment used for this patient, with subsequent clinical improvement and reduced scintigraphic activity.
7. Can Paget's disease be cured?
The source document emphasizes that treatment aims to reduce symptoms, prevent complications such as fractures and deformity, and preserve bone health through long-term monitoring and follow-up rather than describing a definitive cure.
Conclusion
Paget's disease of bone remains one of the most distinctive metabolic skeletal disorders encountered in musculoskeletal radiology. Although its prevalence has declined in many regions, timely recognition remains important because effective treatment can substantially reduce symptoms and limit disease progression.
The presented case highlights several classic imaging findings—including cortical thickening, coarse trabecular remodeling, osseous enlargement, and increased radionuclide uptake on bone scintigraphy—that, when interpreted together with biochemical markers and clinical presentation, strongly support the diagnosis. Notably, the patient's normal total alkaline phosphatase level despite elevated bone-specific alkaline phosphatase underscores the importance of correlating laboratory results with imaging rather than relying on a single biomarker.
From a clinical perspective, bisphosphonate therapy remains the cornerstone of management, with the source case demonstrating symptomatic improvement and reduced scintigraphic activity following risedronate treatment. Long-term follow-up is essential to monitor disease activity, prevent complications, and guide ongoing care.
As musculoskeletal imaging continues to evolve, emerging artificial intelligence technologies may enhance quantitative assessment, longitudinal monitoring, and clinical decision support. However, expert interpretation by radiologists, combined with multidisciplinary clinical correlation, remains fundamental to accurate diagnosis and optimal patient management.
Ultimately, this case illustrates how integrating conventional radiography, bone scintigraphy, laboratory evaluation, and evidence-based therapy provides a comprehensive framework for diagnosing and managing Paget's disease of bone while laying the groundwork for future precision imaging approaches.
References
[1] F. R. Singer et al., "Paget's Disease of Bone: An Endocrine Society Clinical Practice Guideline," Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 12, pp. 4408–4422, Dec. 2014. doi: 10.1210/jc.2014-2910.
[2] S. H. Ralston et al., "Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline," Journal of Bone and Mineral Research, vol. 34, no. 4, pp. 579–604, Apr. 2019. doi: 10.1002/jbmr.3657.
[3] S. H. Ralston et al., "Clinical Guidelines on Paget's Disease of Bone," Journal of Bone and Mineral Research, 2019. doi: 10.1002/jbmr.3873.
[4] P. L. Selby, M. W. J. Davie, S. H. Ralston, and M. D. Stone, "Guidelines on the Management of Paget's Disease of Bone," Bone, vol. 31, no. 3, pp. 366–373, 2002. doi: 10.1016/S8756-3282(02)00817-7.
[5] M. Al-Rashid, D. B. Ramkumar, K. Raskin, J. Schwab, F. J. Hornicek, and S. A. Lozano-Calderón, "Paget Disease of Bone," Orthopedic Clinics of North America, vol. 46, no. 4, pp. 577–585, 2015. doi: 10.1016/j.ocl.2015.06.008.
[6] L. Corral-Gudino, M. Borao-Cengotita-Bengoa, J. Del Pino-Montes, and S. H. Ralston, "Epidemiology of Paget's Disease of Bone: A Systematic Review and Meta-analysis of Secular Changes," Bone, vol. 55, no. 2, pp. 347–352, 2013. doi: 10.1016/j.bone.2013.04.024.
[7] T. P. van Staa, P. Selby, H. G. M. Leufkens, K. W. Lyles, J. M. Sprafka, and C. Cooper, "Incidence and Natural History of Paget's Disease of Bone in England and Wales," Journal of Bone and Mineral Research, vol. 17, no. 3, pp. 465–471, 2002. doi: 10.1359/jbmr.2002.17.3.465.
[8] M. J. Meunier, J. M. Coindre, C. M. Edouard, and M. E. Arlot, "Bone Histomorphometry in Paget's Disease: Quantitative and Dynamic Analysis of Pagetic and Nonpagetic Bone Tissue," Arthritis & Rheumatism, vol. 23, no. 10, pp. 1095–1103, 1980. doi: 10.1002/art.1780231003.
[9] M. Davie, M. Davies, R. Francis, W. Fraser, D. Hosking, and R. Tansley, "Paget's Disease of Bone: A Review of 889 Patients," Bone, vol. 24, Suppl. 5, pp. 11S–12S, 1999. doi: 10.1016/S8756-3282(99)00022-8.
Comments
Post a Comment